Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exposing HIV's weaknesses.

Philip R Tedbury1,2, Stefan G Sarafianos3,2,4

  • 1From the Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, Missouri 65211, tedburyp@missouri.edu.

The Journal of Biological Chemistry
|April 9, 2017
PubMed
Summary

The viral restriction factor SERINC5 inhibits HIV-1 by disrupting the folding of its fusion machinery. This action reduces viral infectivity and enhances antibody effectiveness, revealing new host-virus interaction insights.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

1,3-Dioxolane derived nucleos(t)ides: synthetic strategies, current position, and future promise in antiviral and anticancer drug discovery.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Same author

HIV-1 capsid interactions with Nuclear Pore Complex components support nuclear entry via affinity gradient.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

A novel corneal epithelial cell culture assay for assessing topical antivirals against herpes simplex virus keratitis.

Biochemistry and biophysics reports·2026
Same author

Structural and Mechanistic Basis of F227C-Mediated Hypersusceptibility to Islatravir in HIV-1 Reverse Transcriptase.

bioRxiv : the preprint server for biology·2026
Same author

1,4-Dihydroxy-1,8-napthyridinone (DHN) analogs as HIV-1 reverse transcriptase-associated RNase H inhibitors.

Bioorganic chemistry·2026
Same author

Unraveling the Mechanism of HIV-1 Hypersusceptibility to Tenofovir Imparted by Islatravir Resistance Mutations.

bioRxiv : the preprint server for biology·2026

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • The human immunodeficiency virus type 1 (HIV-1) is a significant global health concern.
  • Viral restriction factors are host proteins that limit viral replication, but their precise mechanisms are often unclear.
  • SERINC5 is a known restriction factor that inhibits HIV-1, yet its mode of action remains largely unknown.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which the restriction factor SERINC5 inhibits HIV-1 infection.
  • To investigate how SERINC5 affects the structural integrity and function of HIV-1's fusion machinery.
  • To understand the implications of SERINC5's action on HIV-1 fusogenicity and susceptibility to neutralizing antibodies.

Main Methods:

  • The study employed techniques to analyze the effects of SERINC5 on HIV-1's structural proteins and fusion complex.

Related Experiment Videos

  • Methods likely included protein folding assays, viral infectivity measurements, and antibody neutralization studies.
  • Computational modeling or biophysical techniques may have been used to assess perturbations in the fusion machinery.

    • Main Results:

    • SERINC5 was shown to suppress HIV-1 fusogenicity, a critical step in viral entry.
    • The restriction factor perturbs the correct folding of HIV-1's fusion machinery, impairing its function.
    • This perturbation leads to increased sensitivity of HIV-1 to neutralizing antibodies.

    Conclusions:

    • SERINC5 inhibits HIV-1 by directly interfering with the structural integrity of the viral fusion complex.
    • The findings provide a novel mechanism for a host restriction factor targeting viral entry.
    • This research highlights the importance of considering host immune components in understanding viral pathogenesis and developing therapeutic strategies.